Copyright Reports & Markets. All rights reserved.

Global Gynaecological Cancer Drugs Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Gynaecological Cancer Drugs

      • 1.1 Definition of Gynaecological Cancer Drugs
      • 1.2 Gynaecological Cancer Drugs Segment By Drug Class
        • 1.2.1 Global Gynaecological Cancer Drugs Production Growth Rate Comparison By Drug Class (2014-2025)
        • 1.2.2 Alkylating Agent
        • 1.2.3 Plant Alkaloid
        • 1.2.4 Anthracyclines
        • 1.2.5 Antitumor Antibiotic
        • 1.2.6 Others
      • 1.3 Gynaecological Cancer Drugs Segment by Applications
        • 1.3.1 Global Gynaecological Cancer Drugs Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospital Pharmacies
        • 1.3.3 Retail Pharmacies
        • 1.3.4 E-commerce
      • 1.4 Global Gynaecological Cancer Drugs Overall Market
        • 1.4.1 Global Gynaecological Cancer Drugs Revenue (2014-2025)
        • 1.4.2 Global Gynaecological Cancer Drugs Production (2014-2025)
        • 1.4.3 North America Gynaecological Cancer Drugs Status and Prospect (2014-2025)
        • 1.4.4 Europe Gynaecological Cancer Drugs Status and Prospect (2014-2025)
        • 1.4.5 China Gynaecological Cancer Drugs Status and Prospect (2014-2025)
        • 1.4.6 Japan Gynaecological Cancer Drugs Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Gynaecological Cancer Drugs Status and Prospect (2014-2025)
        • 1.4.8 India Gynaecological Cancer Drugs Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Gynaecological Cancer Drugs
      • 2.3 Manufacturing Process Analysis of Gynaecological Cancer Drugs
      • 2.4 Industry Chain Structure of Gynaecological Cancer Drugs

      3 Development and Manufacturing Plants Analysis of Gynaecological Cancer Drugs

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Gynaecological Cancer Drugs Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Gynaecological Cancer Drugs
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Gynaecological Cancer Drugs Production and Capacity Analysis
      • 4.2 Gynaecological Cancer Drugs Revenue Analysis
      • 4.3 Gynaecological Cancer Drugs Price Analysis
      • 4.4 Market Concentration Degree

      5 Gynaecological Cancer Drugs Regional Market Analysis

      • 5.1 Gynaecological Cancer Drugs Production by Regions
        • 5.1.1 Global Gynaecological Cancer Drugs Production by Regions
        • 5.1.2 Global Gynaecological Cancer Drugs Revenue by Regions
      • 5.2 Gynaecological Cancer Drugs Consumption by Regions
      • 5.3 North America Gynaecological Cancer Drugs Market Analysis
        • 5.3.1 North America Gynaecological Cancer Drugs Production
        • 5.3.2 North America Gynaecological Cancer Drugs Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Gynaecological Cancer Drugs Import and Export
      • 5.4 Europe Gynaecological Cancer Drugs Market Analysis
        • 5.4.1 Europe Gynaecological Cancer Drugs Production
        • 5.4.2 Europe Gynaecological Cancer Drugs Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Gynaecological Cancer Drugs Import and Export
      • 5.5 China Gynaecological Cancer Drugs Market Analysis
        • 5.5.1 China Gynaecological Cancer Drugs Production
        • 5.5.2 China Gynaecological Cancer Drugs Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Gynaecological Cancer Drugs Import and Export
      • 5.6 Japan Gynaecological Cancer Drugs Market Analysis
        • 5.6.1 Japan Gynaecological Cancer Drugs Production
        • 5.6.2 Japan Gynaecological Cancer Drugs Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Gynaecological Cancer Drugs Import and Export
      • 5.7 Southeast Asia Gynaecological Cancer Drugs Market Analysis
        • 5.7.1 Southeast Asia Gynaecological Cancer Drugs Production
        • 5.7.2 Southeast Asia Gynaecological Cancer Drugs Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Gynaecological Cancer Drugs Import and Export
      • 5.8 India Gynaecological Cancer Drugs Market Analysis
        • 5.8.1 India Gynaecological Cancer Drugs Production
        • 5.8.2 India Gynaecological Cancer Drugs Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Gynaecological Cancer Drugs Import and Export

      6 Gynaecological Cancer Drugs Segment Market Analysis (by Type)

      • 6.1 Global Gynaecological Cancer Drugs Production by Type
      • 6.2 Global Gynaecological Cancer Drugs Revenue by Type
      • 6.3 Gynaecological Cancer Drugs Price by Type

      7 Gynaecological Cancer Drugs Segment Market Analysis (by Application)

      • 7.1 Global Gynaecological Cancer Drugs Consumption by Application
      • 7.2 Global Gynaecological Cancer Drugs Consumption Market Share by Application (2014-2019)

      8 Gynaecological Cancer Drugs Major Manufacturers Analysis

      • 8.1 Roche Holdings
        • 8.1.1 Roche Holdings Gynaecological Cancer Drugs Production Sites and Area Served
        • 8.1.2 Roche Holdings Product Introduction, Application and Specification
        • 8.1.3 Roche Holdings Gynaecological Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 AstraZeneca
        • 8.2.1 AstraZeneca Gynaecological Cancer Drugs Production Sites and Area Served
        • 8.2.2 AstraZeneca Product Introduction, Application and Specification
        • 8.2.3 AstraZeneca Gynaecological Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Sanofi
        • 8.3.1 Sanofi Gynaecological Cancer Drugs Production Sites and Area Served
        • 8.3.2 Sanofi Product Introduction, Application and Specification
        • 8.3.3 Sanofi Gynaecological Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Eli Lilly
        • 8.4.1 Eli Lilly Gynaecological Cancer Drugs Production Sites and Area Served
        • 8.4.2 Eli Lilly Product Introduction, Application and Specification
        • 8.4.3 Eli Lilly Gynaecological Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Pfizer
        • 8.5.1 Pfizer Gynaecological Cancer Drugs Production Sites and Area Served
        • 8.5.2 Pfizer Product Introduction, Application and Specification
        • 8.5.3 Pfizer Gynaecological Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Takeda Pharmaceuticals
        • 8.6.1 Takeda Pharmaceuticals Gynaecological Cancer Drugs Production Sites and Area Served
        • 8.6.2 Takeda Pharmaceuticals Product Introduction, Application and Specification
        • 8.6.3 Takeda Pharmaceuticals Gynaecological Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Bristol-Myers Squibb
        • 8.7.1 Bristol-Myers Squibb Gynaecological Cancer Drugs Production Sites and Area Served
        • 8.7.2 Bristol-Myers Squibb Product Introduction, Application and Specification
        • 8.7.3 Bristol-Myers Squibb Gynaecological Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Merck
        • 8.8.1 Merck Gynaecological Cancer Drugs Production Sites and Area Served
        • 8.8.2 Merck Product Introduction, Application and Specification
        • 8.8.3 Merck Gynaecological Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Dr Reddy’s Laboratories
        • 8.9.1 Dr Reddy’s Laboratories Gynaecological Cancer Drugs Production Sites and Area Served
        • 8.9.2 Dr Reddy’s Laboratories Product Introduction, Application and Specification
        • 8.9.3 Dr Reddy’s Laboratories Gynaecological Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Johnson & Johnson
        • 8.10.1 Johnson & Johnson Gynaecological Cancer Drugs Production Sites and Area Served
        • 8.10.2 Johnson & Johnson Product Introduction, Application and Specification
        • 8.10.3 Johnson & Johnson Gynaecological Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 GlaxoSmithKline
      • 8.12 Apotex
      • 8.13 Hoffmann-La Roche
      • 8.14 Novartis
      • 8.15 Pfizer
      • 8.16 Teva Pharmaceutical

      9 Development Trend of Analysis of Gynaecological Cancer Drugs Market

      • 9.1 Global Gynaecological Cancer Drugs Market Trend Analysis
        • 9.1.1 Global Gynaecological Cancer Drugs Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Gynaecological Cancer Drugs Regional Market Trend
        • 9.2.1 North America Gynaecological Cancer Drugs Forecast 2019-2025
        • 9.2.2 Europe Gynaecological Cancer Drugs Forecast 2019-2025
        • 9.2.3 China Gynaecological Cancer Drugs Forecast 2019-2025
        • 9.2.4 Japan Gynaecological Cancer Drugs Forecast 2019-2025
        • 9.2.5 Southeast Asia Gynaecological Cancer Drugs Forecast 2019-2025
        • 9.2.6 India Gynaecological Cancer Drugs Forecast 2019-2025
      • 9.3 Gynaecological Cancer Drugs Market Trend (Product Type)
      • 9.4 Gynaecological Cancer Drugs Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Gynaecological Cancer Drugs Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Gynaecological cancers are being diagnosed among women on a large scale and are also emerging as one of the leading causes of death in various regions.
        The surge of innovation in gynaecological cancer treatments is attracting all the major participants in the market for cancer drugs. Scientific advances are leading to the new treatment options in the market. Hence, the gynaecological cancer drugs market is also expected to see a significant growth in the coming years.
        Increasing investment by government and the private sector in hospitals and presence of specialist surgeons is also resulting in increased number of patients, thereby leading to the increased use of gynaecological cancer drugs.
        Rise in focus of vendors on emerging markets, such as Asia-Pacific and LAMEA, is expected to boost the market growth. Currently, multinational companies are focusing on investing in the GCC region as well as Latin America and Africa to expand their global reach and gain a competitive advantage.

        The global Gynaecological Cancer Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Gynaecological Cancer Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Gynaecological Cancer Drugs market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Gynaecological Cancer Drugs in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Gynaecological Cancer Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Roche Holdings
        AstraZeneca
        Sanofi
        Eli Lilly
        Pfizer
        Takeda Pharmaceuticals
        Bristol-Myers Squibb
        Merck
        Dr Reddy’s Laboratories
        Johnson & Johnson
        GlaxoSmithKline
        Apotex
        Hoffmann-La Roche
        Novartis
        Pfizer
        Teva Pharmaceutical

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        By Drug Class
        Alkylating Agent
        Plant Alkaloid
        Anthracyclines
        Antitumor Antibiotic
        Others
        By Indication
        Cervical Cancer
        Uterine Cancer
        Ovarian & Fallopian Tube Cancer
        Vulvar Cancer
        Vaginal Cancer

        Segment by Application
        Hospital Pharmacies
        Retail Pharmacies
        E-commerce

        Buy now